Verseau Therapeutics competitorsClear all
Verseau Therapeutics's top competitors include Ionova Life Science, Intrepida Bio, FoRx Therapeutics and Boundless Bio.
 Verseau Therapeutics Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. |  Intrepida Bio Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases. |  FoRx Therapeutics FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer. |  Boundless Bio Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers. | ||
Founding Date | Founding Date 2017 | Founding Date 2016 | Founding Date 2019 | Founding Date 2019 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Bedford, US HQ | Locations HQ | Locations San Diego, US HQ | Locations Basel, CH HQ | Locations San Diego, US HQ |
Employees | Employees 147% decrease | Employees N/A | Employees N/A | Employees 186% increase | Employees 64 |
Twitter followers | Twitter followers 47 | Twitter followers N/A | Twitter followers N/A | Twitter followers 64 | Twitter followers 252 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank N/A | Alexa Website Rank N/A | Alexa Website Rank 333065 | Alexa Website Rank 581835 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A |
Funding | |||||
Latest funding round | Latest funding round $ 50m (over 2 years ago) | Latest funding round $ 17.8m (over 2 years ago) | Latest funding round $ 9.5m (over 2 years ago) | Latest funding round $ 10.8m (about 2 years ago) | Latest funding round $ 46.4m (over 2 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 17.8m | Total funding raised $ 9.5m | Total funding raised $ 10.8m | Total funding raised $ 46.4m |
For sources of this data, please see the company profile
View company profiles
Intrepida Bio
HQ
San Diego, US
Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases.
View companyFoRx Therapeutics
HQ
Basel, CH
Employees
18↑ 6% increase
FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.
View companyBoundless Bio
HQ
San Diego, US
Employees
64
Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers.
View company